Materialise Announces Partnership with HOYA Vision Care

Emerging Technology

Materialise NV (NASDAQ:MTLS) has announced a partnership with HOYA Vision Care, a division of HOYA Group, a global med-tech company and supplier of innovative high-tech and medical products. Together, they will co-create and manufacture parts for high-quality visualisation equipment and vision examination systems.

Materialise NV (NASDAQ:MTLS) has announced a partnership with HOYA Vision Care, a division of HOYA Group, a global med-tech company and supplier of innovative high-tech and medical products. Together, they will co-create and manufacture parts for high-quality visualisation equipment and vision examination systems.
According to the press release:

By working together with Materialise’s design and engineering team and by producing parts in Materialise’s certified additive manufacturing facility HOYA aims to realize a range of tools that empower eye care professionals to deliver an enhanced customer experience and differentiate themselves in the highly competitive eyewear industry.
The first systems to be brought to market as a result of this collaboration are HOYA Vision Simulator and HOYA EyeGenius. The first is a highly innovative tool that allows consumers to experience their new lenses before they buy them, in store by means of virtual reality. The second is a complete vision examination system with a new method to detect and correct fixation disparity.
Materialise Executive Vice President of Production, Bart Van der Schueren, stated, “HOYA has a known commitment to using creativity and innovation to become the leading company in niche markets, making them not only an ideal co-creation partner, but also a company ready to utilize Materialise’s certified manufacturing for high-quality, end-use products. With the first products already making their way onto the market, with great initial feedback, together with HOYA we are proving the added-value that 3D printing is ready to deliver to the entire eyewear industry.”

Click here to read the full press release.


The Conversation (0)
×